证券日报网讯 10月14日晚间，沪光股份发布公告称，公司近日收到中信建投证券股份有限公司（简 称"中信建投"）《关于更换昆山沪光汽车电器股份有限公司2022年非公开发行股票持续督导保荐代表人 的函》，原2022年非公开发行股票项目的持续督导保荐代表人孙林先生因工作变动，无法继续履行保荐 代表人职责。为切实做好持续督导工作，中信建投指派保荐代表人陈启强先生接替孙林先生继续担任公 司2022年非公开发行股票项目的持续督导保荐代表人，继续履行持续督导职责。 （文章来源：证券日报） ...

机器人板块今日延续调整，截至收盘，国证机器人产业指数下跌3.9%，中证智能电动汽车指数下跌 4.1%，中证物联网主题指数下跌4.5%，中证消费电子主题指数下跌4.6%。据Wind数据统计，截至昨 日，机器人ETF易方达（159530）节后连续3日吸金，合计超2亿元。 中信建投证券表示，当前Optimus三代样机发布及量产节奏指引积极，国产链条订单出货、资本化运作 表现积极；市场整体流动性宽松下，看好机器人重回科技成长配置主线。 每日经济新闻 | 跟踪中证物联网主题指数 | | | ·· | | --- | --- | --- | --- | | 该指数聚焦的物联网是智能 终端实现万物互联的重要基 | �日 | 该指数 | 该指数自2015年 | | | 该指数涨跌 | 发动市盈率 | 发布以来估值分位 | | 础,由业务涉及信息采集、 | | | | | 信息传输、物联网应用领域 | -4.5% | 33.3倍 | 50.5% | | 的公司股票组成。 | | | | ...

Core Viewpoint - United Imaging Healthcare is a leading domestic medical imaging equipment manufacturer with strong long-term growth momentum [1] Short-term Outlook - The upcoming new round of equipment renewal projects in 2025 is expected to drive continued improvement in domestic industry bidding trends, following the positive trend observed in the first half of the year [1] - Overseas revenue is anticipated to accelerate growth in the second half of the year, with overall performance expected to achieve high growth on a low base [1] - Adjustments to domestic large medical equipment configuration policies are likely to gradually release demand for mid-to-high-end and high-end products [1] Competitive Advantages - The company is expected to enhance its market share due to advantages in core components, product strength, brand recognition, and distribution channels [1] Mid-term Outlook - The overseas market presents significant growth potential, with the company's overseas revenue share continuously increasing, which is expected to contribute flexibility to the overall growth of the group [1] Long-term Strategy - The company is committed to increasing R&D investment and continuously upgrading its products, which is likely to maintain its leading position in the industry [1] Investment Rating - The company maintains a "Buy" rating [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容 概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不 對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何 損失承擔任何責任。 （於中華人民共和國註冊成立的股份有限公司） （股份代號：6066） 董事會會議通告 中 信 建 投 証 券 股 份 有 限 公 司（「 本公司 」）董 事 會（「 董事會 」）謹 此 宣 佈 ， 董事會會議將於 2025 年 1 0 月 3 0 日（ 星 期 四 ）舉 行 ， 藉 以（ 其 中 包 括 ）審 議及批准本公司及其附屬公司截至 2025 年 9 月 3 0 日止九個月之第三季度 業績及其發佈。 承董事會命 中信建投証券股份有限公司 董事長 劉 成 中國北京 2025 年 1 0 月 1 4 日 於本公告日期，本公司執行董事為劉成先生及金劍華先生；本公司非執 行董事為李岷先生、朱永先生、閆小雷先生、王廣龍先生、楊棟先生、 華淑蕊女士及王華女士；以及本公司獨立非執行董事為浦偉光先生、 賴觀榮先生、張崢先生、吳溪先生及鄭偉先生。 ...

Core Viewpoint - Waterdrop Inc. (WDH.US) has demonstrated strong financial performance with double-digit growth in both revenue and net profit, supported by its AI strategy, which is expected to further enhance profitability and is currently undervalued, leading to a "Buy" rating from CITIC Securities [1] Financial Performance - In Q2 2025, Waterdrop achieved net revenue of 838 million yuan and a net profit attributable to shareholders of 140 million yuan, marking 14 consecutive quarters of profitability [1] - Operating expenses accounted for 38.7% of revenue, a decrease of 6.4 percentage points year-on-year [1] - Insurance-related revenue reached 739 million yuan, up 28.7% year-on-year, with first-year premium income at 3.204 billion yuan, an increase of 80.2% [1] - Short-term and long-term insurance businesses grew by 95% and 45.4% respectively, while digital clinical trial business revenue increased by 34.2% year-on-year [1] AI Strategy and Innovation - Waterdrop's "All in AI" strategy has been fully implemented, reshaping the entire insurance value chain with quantifiable results [2] - The company invests nearly 300 million yuan annually in technology R&D, holding over 100 technology patents and submitting 60 related to large language models, including 9 international patent applications [2] - AI-driven growth has been established in sales and customer acquisition, with the self-developed "Waterdrop Water Guardian" AI insurance expert contributing to a 155% quarter-on-quarter increase in premium [2] - The AI customer service "Bao Xiaohui" covers 100% of online business, providing round-the-clock responses [2] - The introduction of the industry's first AI underwriting expert "KEYI.AI" has reduced processing time for complex underwriting issues by 80%, achieving a 99.8% accuracy rate [2] - Over 92% of customized products launched in 2024 will leverage AI and big data analysis to target traditionally underserved markets [2] Business Structure and Market Expansion - Waterdrop has developed a comprehensive business model encompassing "fundraising + insurance + pharmaceuticals," with high synergy among its segments [3] - The company is actively exploring overseas markets, establishing offices in Hong Kong, Singapore, and the United States, and will continue to focus on user pain points and technology-enabled opportunities in the global insurance market [3]

Core Viewpoint - CITIC Securities announced the issuance of its third tranche of corporate bonds aimed at professional investors, with a fixed interest rate of 2.94% [1] Group 1: Bond Details - The bond is named "23 Xintou G7" and will start paying interest from October 27, 2024, to October 26, 2025 [1] - Each bond has a face value of 1,000 yuan, resulting in an interest payment of 29.4 yuan (including tax) per bond [1]

Group 1 - The core point of the article is that CITIC Securities has announced the issuance of its third phase of corporate bonds aimed at professional investors, with specific details regarding interest payments and rates [1] - The bond is named "23 Xintou G7" and will start paying interest on October 27, 2025, for the period from October 27, 2024, to October 26, 2025 [1] - The coupon rate for this bond is set at 2.94%, with a face value of 1,000 yuan per bond, resulting in an interest distribution of 29.4 yuan (including tax) [1]

Core Points - CITIC Construction Investment Securities (06066.HK) announced that its board meeting will be held on October 30, 2025, to review and approve the third quarter results for the nine months ending September 30, 2025 [1] Group 1 - The board meeting is scheduled for October 30, 2025 [1] - The meeting will include the review and approval of the company's performance [1] - The performance period under review is for the nine months ending September 30, 2025 [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 （於中華人民共和國註冊成立的股份有限公司） （股份代號：6066） 海外監管公告 本 公 告 乃 中 信 建 投 証 券 股 份 有 限 公 司（「本公司」）根 據 香 港 聯 合 交 易 所 有 限公司證券上市規則第13.10B條 而 作 出。 茲 載 列 本 公 司 於 上 海 證 券 交 易 所 網 站 刊 發 之《中 信 建 投 証 券 股 份 有 限 公 司2023年 面 向 專 業 投 資 者 公 開 發 行 公 司 債 券（第 三 期）（品 種 一）2025年付息 公 告》《中 信 建 投 証 券 股 份 有 限 公 司2023年面向專業投資者公開發行公司 債 券（第 三 期）（品 種 二）2025年 付 息 公 告》及《中 信 建 投 証 券 股 份 有 限 公 司 2023年 面 向 專 業 投 資 者 公 開 發 行 ...

中信建投：维持京东集团-SW"买入"评级，目标价193.07港元。 ...